Unresectable stage III non-small cell lung cancer: is Tecemotide a new START for our patients?

J Thorac Dis. 2014 Jun;6(6):574-7. doi: 10.3978/j.issn.2072-1439.2014.05.16.

Authors

Els Wauters¹, Johan Vansteenkiste¹

Affiliation

¹ 1 Vesalius Research Center (VRC), VIB, Leuven, Belgium ; 2 Laboratory for Translational Genetics, Department of Oncology, KU Leuven, Leuven, Belgium ; 3 Respiratory Oncology Unit, Department of Pulmonology, University Hospital KU Leuven, Leuven, Belgium.

PMID: 24976973
PMCID: PMC4073368
DOI: 10.3978/j.issn.2072-1439.2014.05.16

No abstract available